Paula Deen's Diabetes Drug Deal in Jeopardy
Black Enterprise Magazine January-March 2019 Issue

paula deen smilingWith all the talk about the her racist remarks, people probably forgot that Paula Deen revealed she has Type 2 diabetes last year. Deen’s revelations led to a lucrative endorsement deal with a diabetes drug company.

Now, the Danish pharmaceutical company, Novo Nordisk, has suspended its relationship with Deen following her n-word controversy. Deen was paid $6 million for a two-year contract to promote the drug Victoza, the New York Times reports.

From the company’s statement issued on Thursday: “Novo Nordisk and Paula Deen have mutually agreed to suspend our patient education activities for now, while she takes time to focus her attention where it is needed.”

Suspension of Deen’s lucrative deal follows announcements by Target, Home Depot and Wal-Mart that they would stop carrying her products. QVC may be on the verge of doing the same.

Aaron Morrison

Aaron Morrison is an award-winning New York area-based multimedia journalist with a B.A. in Journalism from San Francisco State University. Aaron uses video, audio, photography, the web and social networks to tell captivating stories across all media platforms. Over the last year, Aaron has worked as a general assignment reporter for the Daily Record (Gannett) in northern New Jersey. Before that, he spent the spring of 2010 as the temporary legislative relief reporter for The Associated Press' statehouse bureau in Trenton, N.J. In his down time, Aaron enjoys the company of his friends and extended family. He is a fan of culinary arts and dreams of having a home kitchen so tricked out that Julia Child turns over in her grave.